Federal Circuit decision involving Netlist and Micron shows why finding an error in a patent ruling may not be enough to overturn it. If another independent basis supports the same result, the error may be treated as harmless.
A Federal Circuit decision involving the cancer drug Cabometyx highlights an important distinction between obtaining a patent and having the right to commercialize an invention. A later patent on an improvement may still fall within the scope of an earlier, broader patent.
A Federal Circuit decision shows that filing a patent case in an improper venue may not prevent the court from deciding a substantive challenge to the patent itself. The ruling highlights why patent owners should evaluate venue and early validity risks together before filing suit.
Patent settlements can affect more than the dispute being resolved. A Federal Circuit decision shows how earlier licenses and patent-marking practices can limit damages in later infringement cases.